Insights

Growing R&D Expansion AskBio is actively expanding its research infrastructure, as evidenced by its recent office expansion in the Triangle area, doubling its local footprint. This indicates a strong pipeline of ongoing and future gene therapy development projects, presenting opportunities to offer advanced laboratory, manufacturing, and biotech support services.

Advanced Manufacturing Platforms The company's proprietary Pro10 cell line manufacturing process and extensive capsid library highlight its focus on innovative gene therapy technologies. Sales opportunities exist in supplying specialized bioprocessing equipment, reagents, or support services to enhance its manufacturing capabilities.

Strategic Partnerships AskBio’s collaborations with international entities like Belief Biomed suggest openness to strategic alliances. Engaging in partnership discussions to provide complementary technologies, licensing, or co-development services could be highly beneficial.

Pipeline and Trials With multiple clinical-stage programs, including recent Phase 2 and pivotal studies, AskBio is in an active clinical trial phase. This presents opportunities for sales of clinical trial materials, data management solutions, and bioanalytics services to support its regulatory and development activities.

Financial Growth Potential Revenue estimates between 100 million to 250 million and ongoing investment into pipeline and infrastructure suggest significant growth potential. This creates opportunities to introduce scale-up manufacturing solutions, process optimization, and early-stage funding or investment partnerships to support their expansion goals.

Asklepios BioPharmaceutical, Inc. (AskBio) Tech Stack

Asklepios BioPharmaceutical, Inc. (AskBio) uses 8 technology products and services including CIM Technologies, oEmbed, git, and more. Explore Asklepios BioPharmaceutical, Inc. (AskBio)'s tech stack below.

  • CIM Technologies
    Cad & Graphics
  • oEmbed
    Dev Tools
  • git
    Development
  • Keyence
    IT
  • Microsoft
    Miscellaneous
  • Fortinet
    Network Hardware
  • Linux
    Programming Languages
  • Kadence WP Blocks
    Web Platform Extensions

Media & News

Asklepios BioPharmaceutical, Inc. (AskBio)'s Email Address Formats

Asklepios BioPharmaceutical, Inc. (AskBio) uses at least 1 format(s):
Asklepios BioPharmaceutical, Inc. (AskBio) Email FormatsExamplePercentage
FLast@askbio.comJDoe@askbio.com
95%
First.Last@askbio.comJohn.Doe@askbio.com
3%
FMiddleLast@askbio.comJMichaelDoe@askbio.com
2%

Frequently Asked Questions

Where is Asklepios BioPharmaceutical, Inc. (AskBio)'s headquarters located?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s main headquarters is located at 20 tw Alexander Drive, Suite 110. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s phone number?

Minus sign iconPlus sign icon
You can contact Asklepios BioPharmaceutical, Inc. (AskBio)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s official website and social media links?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s official website is askbio.com and has social profiles on LinkedInCrunchbase.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Asklepios BioPharmaceutical, Inc. (AskBio) have currently?

Minus sign iconPlus sign icon
As of December 2025, Asklepios BioPharmaceutical, Inc. (AskBio) has approximately 503 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: G. P.Chief Development Officer And Chief Medical Officer: C. J.Chief Operating Officer: J. K.. Explore Asklepios BioPharmaceutical, Inc. (AskBio)'s employee directory with LeadIQ.

What industry does Asklepios BioPharmaceutical, Inc. (AskBio) belong to?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio) operates in the Biotechnology Research industry.

What technology does Asklepios BioPharmaceutical, Inc. (AskBio) use?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s tech stack includes CIM TechnologiesoEmbedgitKeyenceMicrosoftFortinetLinuxKadence WP Blocks.

What is Asklepios BioPharmaceutical, Inc. (AskBio)'s email format?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio)'s email format typically follows the pattern of FLast@askbio.com. Find more Asklepios BioPharmaceutical, Inc. (AskBio) email formats with LeadIQ.

How much funding has Asklepios BioPharmaceutical, Inc. (AskBio) raised to date?

Minus sign iconPlus sign icon
As of December 2025, Asklepios BioPharmaceutical, Inc. (AskBio) has raised $2.7M in funding. The last funding round occurred on Sep 02, 2020 for $2.7M.

When was Asklepios BioPharmaceutical, Inc. (AskBio) founded?

Minus sign iconPlus sign icon
Asklepios BioPharmaceutical, Inc. (AskBio) was founded in 2001.

Asklepios BioPharmaceutical, Inc. (AskBio)

Biotechnology ResearchNorth Carolina, United States501-1000 Employees

AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. 

Vision - Pioneering science to create transformative molecular medicines.
Mission - Lead innovative science and drive clinical outcomes to transform people's lives.

Values:
• Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need.
• Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view.
• Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers.
• Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action.
• Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.

Section iconCompany Overview

Headquarters
20 tw Alexander Drive, Suite 110
Phone number
Website
askbio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
501-1000

Section iconFunding & Financials

  • $2.7M

    Asklepios BioPharmaceutical, Inc. (AskBio) has raised a total of $2.7M of funding over 4 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $2.7M.

  • $100M$250M

    Asklepios BioPharmaceutical, Inc. (AskBio)'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $2.7M

    Asklepios BioPharmaceutical, Inc. (AskBio) has raised a total of $2.7M of funding over 4 rounds. Their latest funding round was raised on Sep 02, 2020 in the amount of $2.7M.

  • $100M$250M

    Asklepios BioPharmaceutical, Inc. (AskBio)'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.